2020 Nelson's Pediatric Antimicrobial Therapy (Record no. 3805)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01944nam a22003137a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240305192247.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220106b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781610023528 |
| International Standard Book Number | 1610023528 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | CUHAS-BUGANDO |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | John Scott Bradley |
| 9 (RLIN) | 27895 |
| 245 ## - TITLE STATEMENT | |
| Title | 2020 Nelson's Pediatric Antimicrobial Therapy |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 26th Edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | New York |
| Name of publisher, distributor, etc. | American Academy of Pediatrics |
| Date of publication, distribution, etc. | 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 320 pages |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices.<br/>Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens.<br/><br/>New in the 26th edition:<br/><br/>First pediatric approval of beta-lactam/beta-lactamase inhibitor for CRE (carbapenem-resistant enteric bacilli), ceftazidime-avibactam<br/>Replacement antibiotics for cefotaxime (lack of availability in the US), including ceftriaxone and cefepime (for neonates)<br/>Situations in which ceftaroline is preferred over vancomycin by the Editors for MRSA infections<br/>Updates on management of influenza, including baloxavir (now approved for children >12 years)<br/>New approaches to treatment of mucomycosis<br/>New recommendations for malaria<br/>More than 150 new references!<br/> |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Anti-infective agents |
| 9 (RLIN) | 27896 |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 27897 |
| 9 (RLIN) | 27898 |
| 9 (RLIN) | 19135 |
| 9 (RLIN) | 27899 |
| 9 (RLIN) | 19133 |
| 9 (RLIN) | 19132 |
| 9 (RLIN) | 19130 |
| 9 (RLIN) | 19137 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 01/06/2022 | EBS8275 | 01/06/2022 | 01/06/2022 | E-BOOKS |